The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions. [electronic resource]
Producer: 20180220Description: 1-12 p. digitalISSN:- 1879-1646
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.